Game-Changer? CMS Proposes Rule To Cover Breakthrough Devices On Provisional Basis

The long-awaited proposed rule from the US Medicare agency would allow breakthrough products approved by the FDA to get reimbursed, while manufacturers continue to collect clinical and real-world data.